Risk factors for recurrence in patients with Clostridium difficile infection due to 027 and non-027 ribotypes

艰难梭菌 医学 甲硝唑 内科学 危险系数 多元分析 胃肠病学 置信区间 抗生素 微生物学 生物
作者
Marco Falcone,Giusy Tiseo,Federica Iraci,Giammarco Raponi,Paola Goldoni,D. Delle Rose,Iolanda Santino,Paolo Carfagna,Rita Murri,Massimo Fantoni,Carla Fontana,Maurizio Sanguinetti,Alessio Farcomeni,Guido Antonelli,Antonio Aceti,Claudio Maria Mastroianni,Massimo Andreoni,Roberto Cauda,Nicola Petrosillo,Mario Venditti
出处
期刊:Clinical Microbiology and Infection [Elsevier BV]
卷期号:25 (4): 474-480 被引量:18
标识
DOI:10.1016/j.cmi.2018.06.020
摘要

ObjectivesOur objective was to evaluate factors associated with recurrence in patients with 027+ and 027– Clostridium difficile infection (CDI).MethodsPatients with CDI observed between January and December 2014 in six hospitals were consecutively included in the study. The 027 ribotype was deduced by the presence of tcdB, tcdB, cdt genes and the deletion Δ117 in tcdC (Xpert® C. difficile/Epi). Recurrence was defined as a positive laboratory test result for C. difficile more than 14 days but within 8 weeks after the initial diagnosis date with reappearance of symptoms. To identify factors associated with recurrence in 027+ and 027– CDI, a multivariate analysis was performed in each patient group. Subdistributional hazard ratios (sHRs) and 95% confidence intervals (95%CIs) were calculated.ResultsOverall, 238 patients with 027+ CDI and 267 with 027– CDI were analysed. On multivariate analysis metronidazole monotherapy (sHR 2.380, 95%CI 1.549–3.60, p <0.001) and immunosuppressive treatment (sHR 3.116, 95%CI 1.906–5.090, p <0.001) were factors associated with recurrence in patients with 027+ CDI. In this patient group, metronidazole monotherapy was independently associated with recurrence in both mild/moderate (sHR 1.894, 95%CI 1.051–3.410, p 0.033) and severe CDI (sHR 2.476, 95%CI 1.281–4.790, p 0.007). Conversely, non-severe disease (sHR 3.704, 95%CI 1.437–9.524, p 0.007) and absence of chronic renal failure (sHR 16.129, 95%CI 2.155–125.000, p 0.007) were associated with recurrence in 027– CDI.ConclusionsCompared to vancomycin, metronidazole monotherapy appears less effective in curing CDI without relapse in the 027+ patient group, independently of disease severity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
WhiteSea完成签到,获得积分10
刚刚
zl02完成签到,获得积分10
刚刚
刚刚
en完成签到 ,获得积分10
刚刚
川上富江完成签到 ,获得积分10
1秒前
1秒前
1秒前
沉默的曼凝完成签到,获得积分10
1秒前
dxt完成签到,获得积分10
1秒前
wootoo完成签到,获得积分10
2秒前
帅气无敌的小丁完成签到,获得积分20
2秒前
Tao发布了新的文献求助20
2秒前
Zhangyuanjie完成签到,获得积分10
2秒前
2秒前
追寻微笑完成签到 ,获得积分10
2秒前
我是谁的应助被华宇蓝采纳,获得50
3秒前
凌L发布了新的文献求助10
3秒前
伍六七完成签到,获得积分10
3秒前
归海子轩完成签到 ,获得积分10
4秒前
超级无敌大富婆完成签到,获得积分10
4秒前
liuyuanhao完成签到,获得积分10
4秒前
5秒前
5秒前
5秒前
dopamine发布了新的文献求助10
5秒前
NexusExplorer的应助被张帅奔采纳,获得10
5秒前
整齐的忆彤完成签到,获得积分10
5秒前
elidan完成签到,获得积分10
5秒前
酷波er的应助被优雅盼海采纳,获得10
5秒前
5秒前
6秒前
roselau完成签到,获得积分10
6秒前
木可完成签到,获得积分10
7秒前
7秒前
Nana完成签到 ,获得积分10
8秒前
热心芹完成签到,获得积分10
8秒前
lmn发布了新的文献求助10
8秒前
风趣的洙完成签到,获得积分10
8秒前
乐乐的应助被cccxy采纳,获得10
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173692
求助须知:如何正确求助?哪些是违规求助? 9565811
关于积分的说明 21782566
捐赠科研通 7767850
什么是DOI,文献DOI怎么找? 3431604
关于科研通互助平台的介绍 2555860
邀请新用户注册赠送积分活动 2476903